News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
596,882 Results
Type
Article (22596)
Company Profile (341)
Press Release (573937)
Multimedia
Podcasts (132)
Webinars (21)
Section
Business (196101)
Career Advice (684)
Deals (30108)
Drug Delivery (76)
Drug Development (71814)
Employer Resources (57)
FDA (12450)
Job Trends (10828)
News (287927)
Policy (22602)
Tag
2025 Best Places to Work (15)
2026 Best Places to Work (25)
2027 BioMidwest Digital (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (10)
2027 Biotech Beach Standard (5)
2027 Genetown Digital (3)
2027 Genetown Elite (1)
2027 Genetown Standard (5)
2027 NextGen (8)
2027 Pharm Country Digital (2)
2027 Pharm Country Standard (4)
40 Under 40 (4)
Academia (1337)
Accelerated approval (52)
ADA (39)
Adcomms (21)
Allergies (159)
Alliances (41527)
ALS (249)
Alzheimer's disease (1583)
Antibody-drug conjugate (ADC) (666)
Approvals (13162)
Artificial intelligence (700)
ASCO (278)
Autoimmune disease (455)
Automation (49)
Bankruptcy (311)
Belgium (29)
Best Places to Work (8682)
BIO (68)
Biologics (82)
BIOSECURE Act (6)
Biosimilars (203)
BioSpace Insights (96)
Biotechnology (229)
Bispecific (54)
Bladder cancer (195)
Brain cancer (77)
Breast cancer (759)
Cancer (6394)
Cardiovascular disease (483)
Career advice (606)
Career pathing (25)
CAR-T (377)
CDC (17)
CDMO (143)
Celiac Disease (4)
Cell therapy (1005)
Cervical cancer (49)
Clinical research (64950)
Collaboration (2281)
Commercialization (57)
Company closure (4)
Compensation (1766)
Complete response letters (80)
COVID-19 (1520)
CRISPR (141)
CRO (3)
C-suite (1358)
Cystic fibrosis (151)
Data (9452)
Denatured (31)
Depression (173)
Dermatology (164)
Diabetes (565)
Diagnostics (5062)
Digital health (50)
Diversity (6)
Diversity, equity & inclusion (16)
Drug discovery (402)
Drug pricing (65)
Drug shortages (7)
Duchenne muscular dystrophy (363)
Earnings (81702)
Editorial (42)
Employer branding (11)
Employer resources (53)
ESMO (382)
Events (106359)
Executive appointments (1072)
Eye disease (14)
FDA (16480)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (38)
Funding (1847)
Gene editing (287)
Generative AI (55)
Gene therapy (808)
GLP-1 (757)
Government (1929)
Grass and pollen (4)
Guidances (343)
Healthcare (12658)
Hematology (181)
HIV (81)
Huntington's disease (78)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (130)
Immunology and inflammation (315)
Immuno-oncology (136)
Indications (253)
Infectious disease (1811)
Inflammatory bowel disease (234)
Inflation Reduction Act (12)
Influenza (104)
Intellectual property (338)
Interviews (137)
IPO (14456)
IRA (15)
Job creations (2492)
Job search strategy (501)
JPM (43)
Kidney cancer (23)
Kidney disease (145)
Labor market (51)
Layoffs (340)
Leadership (34)
Legal (5749)
Licensing (105)
Liver cancer (74)
Longevity (46)
Lung cancer (903)
Lung diease (21)
Lymphoma (457)
Machine learning (51)
Management (18)
Manufacturing (1010)
Marketing (32)
MASH (207)
Medical affairs (4)
Medical device (10150)
Medtech (10378)
Mergers & acquisitions (16978)
Metabolic disorders (1396)
Middle East (1)
mRNA (242)
Multiple sclerosis (199)
Multispecific (6)
NASH (14)
Netherlands (19)
Neurodegenerative disease (509)
Neuropsychiatric disorders (114)
Neuroscience (3361)
Neurotech (3)
NextGen: Class of 2026 (4340)
Non-profit (1747)
Now hiring (49)
Obesity (583)
Opinion (186)
Ovarian cancer (261)
Pain (269)
Pancreatic cancer (374)
Parkinson's disease (411)
Partnered (30)
Patents (665)
Patient advocacy (8)
Patient recruitment (847)
Patient selection (95)
Peanut (60)
People (50661)
Peptides (32)
Pharmaceutical (53)
Pharmacy benefit managers (16)
Phase 1 (21372)
Phase 2 (29294)
Phase 3 (20039)
Pipeline (11987)
Policy (134)
Postmarket research (1915)
Preclinical (9136)
Press Release (52)
Prostate cancer (329)
Psychedelics (87)
Radioligand (3)
Radiopharmaceuticals (385)
Rare diseases (1269)
Real estate (3930)
Recruiting (22)
Regenerative medicine (27)
Regulatory (20372)
Reports (41)
Research institute (1413)
Resumes & cover letters (83)
Rett syndrome (58)
RNA editing (38)
RSV (61)
Schizophrenia (192)
Series A (347)
Series B (236)
Service/supplier (5)
Sickle cell disease (128)
Special edition (25)
Spinal muscular atrophy (162)
Sponsored (26)
Startups (3169)
State (1)
Stem cells (7)
Stomach cancer (10)
Substance use disorders (22)
Supply chain (82)
Switzerland (14)
Tariffs (23)
The Weekly (99)
Vaccines (653)
Venture capital (126)
Weight loss (303)
Wet AMD (5)
Women's health (131)
Worklife (7)
Date
Today (83)
Last 7 days (901)
Last 30 days (3179)
Last 365 days (26463)
2026 (23499)
2025 (26001)
2024 (30274)
2023 (34250)
2022 (43718)
2021 (46241)
2020 (41531)
2019 (30820)
2018 (23232)
2017 (24543)
2016 (23172)
2015 (29410)
2014 (25241)
2013 (20980)
2012 (22796)
2011 (23078)
2010 (22623)
Location
Africa (387)
Alabama (101)
Alaska (3)
Arizona (375)
Arkansas (15)
Asia (29814)
Australia (4653)
California (15402)
Canada (4103)
China (1565)
Colorado (648)
Connecticut (608)
Delaware (414)
Europe (56163)
Florida (2233)
Georgia (463)
Hawaii (4)
Idaho (47)
Illinois (1079)
India (108)
Indiana (500)
Iowa (25)
Japan (634)
Kansas (120)
Kentucky (43)
Louisiana (48)
Maine (38)
Maryland (1609)
Massachusetts (11083)
Michigan (341)
Minnesota (704)
Mississippi (6)
Missouri (104)
Montana (32)
Nebraska (14)
Nevada (161)
New Hampshire (78)
New Jersey (3656)
New Mexico (20)
New York (3762)
North Carolina (1866)
North Dakota (11)
Northern California (8006)
Ohio (387)
Oklahoma (16)
Oregon (39)
Pennsylvania (2963)
Puerto Rico (28)
Rhode Island (50)
South America (582)
South Carolina (88)
South Dakota (1)
Southern California (6157)
Tennessee (162)
Texas (2498)
United States (51971)
Utah (453)
Vermont (1)
Virginia (286)
Washington D.C. (53)
Washington State (1222)
West Virginia (2)
Wisconsin (128)
Wyoming (2)
596,882 Results for "walking fish therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arima Genomics Study Shows Hi-C Reveals Clinically Important Rearrangements Beyond Routine FISH
October 29, 2026
·
5 min read
Business
Walking Fish Therapeutics Expands Leadership Team
Walking Fish Therapeutics, a leader in B cell engineering, announced the promotion of Julie Kim, PharmD, MS, to Chief Business Officer.
June 1, 2023
·
3 min read
Obesity
Kailera walks path paved by Lilly in post-IPO ‘catalyst-rich period’
Kailera Therapeutics is advancing a pipeline of weight loss medicines that mirrors Eli Lilly’s: an injectable GLP-1/GIP dual agonist like Zepbound, an oral GLP-1 like Foundayo and a triple-G therapy like retatrutide.
May 28, 2026
·
2 min read
·
Tristan Manalac
Duchenne muscular dystrophy
Sarepta could be ‘potential turnaround story’ with catalysts lined up into 2027
Jefferies analysts made the prediction after Sarepta Therapeutics, which has endured nothing short of a saga with the Duchenne muscular dystrophy gene therapy Elevidys, presented data this week showing its clinically meaningful benefit in older patients who are able to walk.
October 2, 2026
·
3 min read
·
Heather McKenzie
Business
MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform
MaxCyte, Inc. today announced the signing of a strategic platform license (SPL) with Walking Fish Therapeutics , Inc. a biotechnology company that is rapidly advancing B cell-based therapeutics.
May 4, 2023
·
3 min read
Press Releases
Kerecis Drives the Fish-Skin Conversation at Leading European Wound Conference - EWMA-DEWU 2026
May 5, 2026
·
5 min read
Press Releases
New Clinical Data on Fish-Skin Grafts to Headline Kerecis Presence at SAWC Spring
April 8, 2026
·
6 min read
Biotech Bay
Walking Fish Therapeutics Closes $73 Million Series A Financing
Walking Fish Therapeutics , a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising a total of $73 million.
February 16, 2022
·
2 min read
China
China’s licensing deals soar as US biotechs enjoy a bumper M&A year
China may be taking the majority of licensing deals this year but those transactions don’t tell the whole story, according to Locust Walk, which points to the spike in M&A among U.S. biotechs as leveling the playing field.
October 21, 2026
·
3 min read
·
Annalee Armstrong
Parkinson’s disease
Reeling from past failures, Parkinson’s pipeline enters ‘era of diversification’
While some drugmakers continue to walk the alpha-synuclein antibody path, others like AC Immune opt for new approaches that could bring the first-ever disease-modifying therapy for Parkinson’s disease.
September 8, 2026
·
6 min read
·
Michael Gibney
1 of 59,689
Next
